World's Best Scientists 2026 revealed!
Armand Bensussan

Armand Bensussan

D-Index & Metrics

Immunology

D-Index
80
Citations
21555
World Ranking
1641
National Ranking
65

Medicine

D-Index
80
Citations
21656
World Ranking
17196
National Ranking
567

Armand Bensussan publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Armand Bensussan sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 546 publications — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Armand Bensussan D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Armand Bensussan sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 80 D-Index — 68th percentile

68% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Armand Bensussan is affiliated with Hôpital Saint-Louis in France and has a significant research footprint in the fields of Medicine and Immunology and Microbiology. Their scholarly work spans key subfields including Immunology, Dermatology, Oncology, Pathology and Forensic Medicine, and Molecular Biology.

Their research primarily focuses on topics such as Cutaneous lymphoproliferative disorders research, Immune Cell Function and Interaction, CAR-T cell therapy research, Lymphoma Diagnosis and Treatment, T-cell and B-cell Immunology, Monoclonal and Polyclonal Antibodies Research, and Immunotherapy and Immune Responses.

Frequent collaborators in their work include M. Bagot, Laurence Michel, Anne Marie-Cardine, Martine Bagot, and Jean-David Bouaziz.

Bensussan has contributed to numerous papers published in several prominent scientific journals. These include:

  • MDA5+ Dermatomyositis Is Associated with Stronger Skin Type I Interferon Transcriptomic Signature with Upregulation of IFN-κ Transcript, 2020, Journal of Investigative Dermatology
  • Cutaneous Wound Healing: A Review about Innate Immune Response and Current Therapeutic Applications, 2022, Mediators of Inflammation
  • Vieillissement cutané, 2020, médecine/sciences
  • Bi38-3 is a novel CD38/CD3 bispecific T-cell engager with low toxicity for the treatment of multiple myeloma, 2020, Haematologica
  • Cannabinoids as Immune System Modulators: Cannabidiol Potential Therapeutic Approaches and Limitations, 2022, Cannabis and Cannabinoid Research

The most frequent venues for Bensussan's publications include:

  • Journal of Investigative Dermatology
  • European Journal of Cancer
  • Annales de Dermatologie et de Vénéréologie
  • Frontiers in Immunology
  • Blood

Best Publications

  • Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8.

    Sylvie Fournel;Maryse Aguerre-Girr;Xavier Huc;Françoise Lenfant

  • Toxic epidermal necrolysis: Effector cells are drug-specific cytotoxic T cells

    Amal Nassif;Armand Bensussan;Laurence Boumsell;Aurelien Deniaud

  • Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies.

    Ivan Perrot;Henri-Alexandre Michaud;Marc Giraudon-Paoli;Séverine Augier

  • Generation of monoclonal antibodies to a human natural killer clone. Characterization of two natural killer-associated antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes.

    T Hercend;J D Griffin;A Bensussan;R E Schmidt

  • Drug Specific Cytotoxic T-Cells in the Skin Lesions of a Patient with Toxic Epidermal Necrolysis

    Amal Nassif;Armand Bensussan;Guillaume Dorothée;Fathia Mami-Chouaib

  • Human CD100, a novel leukocyte semaphorin that promotes B-cell aggregation and differentiation.

    Kathryn T. Hall;Laurence Boumsell;Joachim L. Schultze;Vassiliki A. Boussiotis

  • IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro.

    Jean-David Bouaziz;Sebastien Calbo;Sebastien Calbo;Sebastien Calbo;Maud Maho-Vaillant;Maud Maho-Vaillant;Anne Saussine;Anne Saussine

  • Inhibition of CD39 Enzymatic Function at the Surface of Tumor Cells Alleviates Their Immunosuppressive Activity

    Jeremy Bastid;Anne Regairaz;Nathalie Bonnefoy;Cécile Déjou

  • CD5-CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas.

    Jean-François Emile;Marie-Laure Boulland;Corinne Haioun;Panagiotis Kanavaros

  • The Human T-Cell Receptor

    Oreste Acuto;Marina Fabbi;Armand Bensussan;Claudio Milanese

  • Correction: Corrigendum: Minimizing the risk of allo-sensitization to optimize the benefit of allogeneic cardiac-derived stem/progenitor cells

    Hocine R. Hocine;Hicham El Costa;Noemie Dam;Jerome Giustiniani

  • Evaluation of the potential role of cytokines in toxic epidermal necrolysis.

    Amal Nassif;Homayoun Moslehi;Homayoun Moslehi;Sabine Le Gouvello;Martine Bagot

  • Biology and clinical applications

    Salem Chouaib;Zohra Soua;Jean-Michel Mencia-Huerta;Armand Bensussan

  • IFNα kinoid vaccine-induced neutralizing antibodies prevent clinical manifestations in a lupus flare murine model

    Daniel Zagury;Hélène Le Buanec;Alexis Mathian;Patrick Larcier

  • Soluble HLA-G1 inhibits angiogenesis through an apoptotic pathway and by direct binding to CD160 receptor expressed by endothelial cells

    Pierre Fons;Sophie Chabot;Judith E. Cartwright;Francoise Lenfant

  • ENTPD1/CD39 is a promising therapeutic target in oncology

    Bastid J;Cottalorda-Regairaz A;Alberici G;Bonnefoy N;Bonnefoy N

  • Activation of human thymocytes via the 50KD T11 sheep erythrocyte binding protein induces the expression of interleukin 2 receptors on both T3+ and T3- populations.

    D A Fox;R E Hussey;K A Fitzgerald;A Bensussan

  • CD molecules 2006 — Human cell differentiation molecules

    Heddy Zola;Bernadette Swart;Alison Banham;Simon Barry

  • The Uterine Immune Profile May Help Women With Repeated Unexplained Embryo Implantation Failure After In Vitro Fertilization

    Nathalie Lédée;Nathalie Lédée;Marie Petitbarat;Lucie Chevrier;Dominique Vitoux

  • Antigenic peptides recognized by T lymphocytes from AIDS viral envelope-immune humans.

    J. A. Berzofsky;A. Bensussan;K. B. Cease;K. B. Cease;J. F. Bourge

  • CD158k/KIR3DL2 is a new phenotypic marker of Sezary cells: relevance for the diagnosis and follow-up of Sezary syndrome.

    Ewa Poszepczynska-Guigné;Valérie Schiavon;Michel D'Incan;Hamid Echchakir

Frequent Co-Authors

Martine Bagot
Martine Bagot Université Paris Cité
Gérard Chaouat
Gérard Chaouat Grenoble Alpes University
Antoine Toubert
Antoine Toubert Université Paris Cité
Bernard Grandchamp
Bernard Grandchamp Université Paris Cité
Christopher D. Buckley
Christopher D. Buckley University of Oxford
Anne Janin
Anne Janin Université Paris Cité
David Y. Mason
David Y. Mason John Radcliffe Hospital
Eric Vivier
Eric Vivier Aix-Marseille University
Jean Dausset
Jean Dausset Grenoble Alpes University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology opens doors to diverse career pathways, especially in healthcare and research. For those interested in clinical practice, transitioning from roles like a Family Nurse Practitioner (FNP) to more specialized fields is a common progression. Resources on how to transition from fnp to acute care np provide valuable guidance for professionals aiming to deepen their expertise and expand their scope of practice.

Accelerated nursing programs offer faster routes for acquiring advanced nursing credentials, which can complement an immunology background. Exploring a nurse practitioner accelerated program is especially useful for those who want to become nurse practitioners swiftly without compromising quality education.

For individuals entering nursing without prior experience, online rn programs for non nurses in florida provide excellent opportunities to gain foundational nursing knowledge remotely. These programs make it easier to start a nursing career while continuing to study immunology.

Additionally, many students benefit from 12-month programs designed to expedite their education and entry into the workforce. Reviews of 12-month accelerated nursing programs highlight accessible options that balance speed with comprehensive training, ideal for busy professionals or career changers.

Best Scientists Citing Armand Bensussan

Trending Scientists

Recently Published Articles